Cystatin from Filarial Parasites Suppress the Clinical Symptoms and Pathology of Experimentally Induced Colitis in Mice by Inducing T-Regulatory Cells, B1-Cells, and Alternatively Activated Macrophages

Potential alternative therapeutic strategies for immune-mediated disorders are being increasingly recognized and are studied extensively. We previously reported the therapeutic potential of Brugia malayi derived recombinant cystatin (rBmaCys) in attenuating clinical symptoms of experimental colitis....

Descripción completa

Detalles Bibliográficos
Autores principales: Bisht, Nalini, Khatri, Vishal, Chauhan, Nikhil, Kalyanasundaram, Ramaswamy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966632/
https://www.ncbi.nlm.nih.gov/pubmed/31683524
http://dx.doi.org/10.3390/biomedicines7040085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966632/
https://www.ncbi.nlm.nih.gov/pubmed/31683524
http://dx.doi.org/10.3390/biomedicines7040085

Ejemplares similares